NAMSCommon stockNASDAQ
NAMS Common stock
This is the ticker-level security page. The issuer is NewAmsterdam Pharma Co N.V..
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$45.6M
Net income TTM
-$241.6M
Total assets
Not available
Total debt
Not available
Total equity
Not available
Profit margin
Not available
ROE
Not available
ROA
Not available
Latest issuer financial snapshot: 2024-12-31